kabutan

SAPPORO CLINICAL LAB, 9% Increase in Ordinary Profit for The Current Fiscal Year

Mon May 12, 2025 3:30 pm JST Earnings

9776 SAPPORO CLINICAL LABORATORY INC. 【J-GAAP】

Earnings Report

SAPPORO CLINICAL LABORATORY INC. <9776> [TSE Std] announced its financial results after the market closed on May 12th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 expanded 37.5% from the previous period to 707 million yen. For the fiscal year ending March 2026, the consolidated ordinary profit is expected to grow by 9.1% to 771 million yen.

In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit increased 58.8% from the same period last year, reaching 154 million yen. The operating profit margin improved from 2.5% in the same period last year to 3.4%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 20,127 1,008 1,159 568 170.5 23 May 12, 2023 J-GAAP
Mar, 2024 19,682 534 514 380 114.1 23 May 13, 2024 J-GAAP
Mar, 2025 20,131 706 707 464 148.4 23 May 12, 2025 J-GAAP
YoY +2.3% +32.2% +37.5% +22.1% +30.0%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 20,131 706 707 464 148.4 23 May 7, 2025 J-GAAP
Mar, 2025 Results 20,131 706 707 464 148.4 23 May 12, 2025 J-GAAP
Revision Rate 0.0% 0.0% 0.0% 0.0% 0.0%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 9,996 337 343 222 70.9 0 Nov 8, 2024 J-GAAP
Apr - Sep, 2025 Guidance 10,312 366 365 238 76.3 0 May 12, 2025 J-GAAP
YoY +3.2% +8.6% +6.4% +7.2% +7.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 19,682 534 514 380 114.1 23 May 13, 2024 J-GAAP
Mar, 2025 20,131 706 707 464 148.4 23 May 12, 2025 J-GAAP
Mar, 2026 Guidance 20,688 775 771 505 161.9 23 May 12, 2025 J-GAAP
YoY +2.8% +9.8% +9.1% +8.8% +9.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 4,830 120 97 69 20.7 2.5 May 13, 2024 J-GAAP
Apr - Jun, 2024 4,999 98 102 56 17.9 2.0 Aug 5, 2024 J-GAAP
Jul - Sep, 2024 4,997 239 241 166 53.0 4.8 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 5,279 204 210 145 46.3 3.9 Feb 12, 2025 J-GAAP
Jan - Mar, 2025 4,856 165 154 97 31.0 3.4 May 12, 2025 J-GAAP
YoY +0.5% +37.5% +58.8% +40.6% +49.6%

Related Articles